We use cookies to so our web site can function correctly. By Clicking "OK" or by clicking into any content on this site, you agree to allow cookies to be placed. To find out more visit the cookies section of our privacy policy.

Privacy Statement

A cookie is a small file which asks permission to be placed on your computer's hard drive. Once you agree, the file is added and the cookie helps analyse web traffic or lets you know when you visit a particular site. Cookies allow web applications to respond to you as an individual. The web application can tailor its operations to your needs, likes and dislikes by gathering and remembering information about your preferences.

We use traffic log cookies to identify which pages are being used. This helps us analyse data about web page traffic and improve our website in order to tailor it to customer needs. We only use this information for statistical analysis purposes.

Overall, cookies help us provide you with a better website, by enabling us to monitor which pages you find useful and which you do not. A cookie in no way gives us access to your computer or any information about you, other than the data you choose to share with us.

Cookie group mandatory

(Req)
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms.
You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

These cookies are required

Functional

These cookies allow us to adtertise our products to you and allow us to pass this information on to our trusted third parties so that they can advertise our products to you on our behalf
All information these cookies collect is aggregated and therefore anonymous. No personal inforation is shared to third parties. Any personal information collected while using our website could be used for direct marketing from HCA only

Marketing

These cookies allow us to advertise our products to you and allow us to pass this information on to our trusted third parties so that they can advertise our products to you on our behalf
All information these cookies collect is aggregated and therefore anonymous. No personal inforation is shared to third parties. Any personal information collected while using our website could be used for direct marketing from HCA only

Performance Cookies

These cookies allow us to know which pages are the most and least popular and see how visitors move around the site.  All information collect is annonomas unless you provide personal information to us.
If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Consultant Haematologist Emma Drasar

Dr Emma Drasar

MBBS MRCP FRCPath PhD

Consultant Haematologist

Specialty
Fixed Price Packages

About

  • Biography icon plus

    Emma Drasar is a Consultant Haematologist working between UCLH and the Whittington NHS trust. She trained at St Barts and the Royal London School of Medicine, University of London and qualified in 2001 and was awarded MRCP in 2006. She completed her Haematology training at King's College Hospital being awarded FRCPath in 2015. She is a member of the British Society of Haematology and the UK Haemoglobinopathy Forum.

    Dr Drasar was appointed Clinical Lecturer in Sickle Cell Disease at King’s from 2009 to 2013. During this time she was awarded a PhD based on research into markers of severity and predictors of organ dysfunction in sickle cell disease and in 2013 was awarded the Early Stage Investigator prize from the British Society of Haematology. She is a Principle Investigator for the BELIEVE trial using luspatacept to improve anaemia in thalassaemia and a Sub-Investigator on a La Jolla trial looking at alternative approaches to iron chelation. She has published 20 papers in peer reviewed scientific journals and is currently an honorary Senior Lecturer at University College London.

    Dr Drasar is the Thalassaemia lead for the UK Peer Review process, assessing specialist centres for their compliance with the UK standards of care for haemoglobinopathy patients and is also the the Network Lead for the North Central London Red cell Network. During her time as network lead Dr Drasar has led on a number of initiatives to improve patient care. This includes holding joint educational days with the North Middlesex and East Anglia Network, standardising of clinical guidelines across the network, standardising the referral process for acutely unwell patients and setting up a weekly network MDT for elective queries. Both Whittington Health and UCLH were successful in fully achieving the requested standards for the NHSE Network CQUIN and have achieved specialist haemoglobinopathy team status. She has also led on establishing an automated apheresis service at the Whittington (including 24 hour emergency cover) via NHSBT and a transient elastography service to monitor patients with liver complications.

    She is passionate about teaching and improving trainee’s knowledge of managing red cell and iron disorders, helping to initiate a British Society of Haematology sponsored course in haematology for Core Medical Trainees. With Dr Noemi Roy (Oxford) she has also created the “Red Cell Roadshow” for Haematology trainees providing an introduction to haemoglobinopathies, targeted at low prevalence areas, which has been extremely successful. She also is a regular speaker at UK Thalassaemia Society and “Red Cells R Us” patients support meetings.

  • Clinical interests icon plus

    • Sickle Cell Disease
    • Thalassaemia
    • Rare Anaemias
    • Iron disorders including deficiency and iron overload (Haemochromatosis)
    • Hyperferritinaemia
     
  • Publications icon plus

    1. Challenges of blood transfusions in β-thalassemia.
    Shah FT, Sayani F, Trompeter S, Drasar E, Piga A.
    Blood Rev. 2019 Sep; PMID: 31324412

    2. Reducing inappropriately suspended VTE prophylaxis through a multidisciplinary shared learning programme and electronic prompting.
    Brewer CF, Ip D, Drasar E, Aghakhani P.
    BMJ Open Qual. 2019 Mar PMID: 31259270

    3. Increased prevalence of renal cysts in patients with sickle cell disease.
    Meeks D, Navaratnarajah A, Drasar E, Jaffer O, Wilkins CJ, Thein SL, Sharpe CC.
    BMC Nephrol. 2017 Sep PMID: 28934953

    4. Interim assessment of liver damage in patients with sickle cell disease using new non-invasive techniques
    Drasar E, Fitzpatrick E, Gardner K, Awogbade M, Dhawan A, Bomford A, Suddle A, Thein SL
    Br J Haematol. 2016 In press

    5. Survival in adults with sickle cell disease in a high-income setting.
    Gardner K, Douiri A, Drasar E, Allman M, Mwirigi A, Awogbade M, Thein SL.
    Blood. 2016 PMID: 27439910

    6. Tissue Iron Distribution Assessed by MRI in Patients with Iron Loading Anemias.
    Gutiérrez L, House MJ, Vasavda N, Drašar E, Gonzalez-Gascon Y Marin I, Kulasekararaj AG, St Pierre TG, Thein SL.
    PLoS One. 2015 PMID: 26406992

    7. Pulmonary Haemodynamics in Sickle Cell Disease Are Driven Predominantly by a High-Output State Rather Than Elevated Pulmonary Vascular Resistance: A Prospective 3-Dimensional Echocardiography/Doppler Study
    Mushemi-Blake S, Melikian N, Drasar E, Bhan A, Lunt A, Desai SR, Greenough A, Monaghan MJ, Thein SL, Shah AM
    PLoS One 2015 PMID: 26270484

    8. The clinical significance of K-Cl cotransport activity in red cells of patients with HbSC disease.
    Rees DC, Thein SL, Osei A, Drasar E, Tewari S, Hannemann A, Gibson JS.
    Hematologica. 2015 PMID: 25749827

    9. Spectral domain optical coherence tomography in patients with sickle cell disease.
    Mathew R, Bafiq R, Ramu J, Pearce E, Richardson M, Drasar E, Thein SL, Sivaprasad S.
    Br J Ophthalmol. 2015 PMID: 25595176

    10. Global Genetic Architecture of an Erythroid Quantitative Trait Locus, HMIP-2.
    Menzel S, Rooks H, Zelenika D, Mtatiro SN, Gnanakulasekaran A, Drasar E, Cox S, Liu L, Masood M, Silver N, Garner C, Vasavda N, Howard J, Makani J, Adekile A, Pace B, Spector T, Farrall M, Lathrop M, Thein SL.
    Ann Hum Genet. 2014 PMID: 25069958

    11. Leukocyte Telomere Length in Patients with Sickle Cell Disease
    Drasar E, Jiang J, Gardner K, Howard J, Vulliamy T, Vasavda N, Thein SL
    Br J Haematol. 2014 PMID: 24666270

    12. The Effect of Duffy Antigen Receptor for Chemokines (DARC) on Severity in Sickle Cell Disease
    Drasar E, Menzel S, Fulford T, and Thein SL
    Hematologica 2013 PMID: 23753024

    13. Genetic determinants of haemolysis in sickle cell anaemia.
    Milton JN, Rooks H, Drasar E, McCabe EL, Baldwin CT, Melista E, Gordeuk VR, Nouraie M, Kato GR, Minniti C, Taylor J, Campbell A, Luchtman-Jones L, Rana S, Castro O, Zhang Y, Thein SL, Sebastiani P, Gladwin MT; Walk- PHAAST Investigators, Steinberg MH.
    Br J Haematol. 2013 PMID: 23406172

    14. Renal iron load in sickle cell disease is influenced by severity of haemolysis.
    Vasavda N, Gutiérrez L, House MJ, Drašar E, St Pierre TG, Thein SL.
    Br J Haematol. 2012 PMID: 22409346

    15. Serum ferritin and total units transfused for assessing iron overload in adults with sickle cell disease.
    Drasar E, Vasavda N, Igbineweka N, Awogbade M, Allman M, Thein SL.
    Br J Haematol. 2012 PMID: 22332939

    16. Effects of co-existing α-thalassaemia in sickle cell disease on hydroxycarbamide therapy and circulating nucleic acids.
    Vasavda N, Woodley C, Allman M, Drašar E, Awogbade M, Howard J, Thein SL.
    Br J Haematol. 2012 PMID: 22082280

    17. Association between haemolysis and microalbuminuria in adults with sickle cell anaemia.
    Day, T*, Drasar E*, Sharpe, C and Thein SL.
    Hematologica. 2012 PMID: 21993677 * Joint first authors


    18. Changing pattern of hospital admissions of children with sickle cell disease over the last 50 years.
    Day TG, Thein SL, Drasar E, Dick MC, Height SE, O'Driscoll S, Rees DC.
    J Pediatr Hematol Oncol. 2012 PMID: 21941140

    19. Blood transfusion among adults with sickle cell disease – a single institution experience over ten years
    Drasar E, Igbineweka N, Vasavda N, Free M, et al.
    Br J Haematol 2011. PMID: 21275951

    20. Genetics of fetal hemoglobin in Tanzanian and British patients with sickle cell anemia.
    Makani J, Menzel S, Nkya S, Cox SE, Drasar E, Soka D, et al.
    Blood 2010. PMID: 21068433

  • Awards and recognitions icon plus

    British Society of Haematology Early Stage Investigator Prize 2013

  • Professional bodies icon plus

    - Royal College of Physicians
    - Royal College of Pathologists

Practice locations

NHS base

University College London Hospital NHS Foundation Trust and The Whittington Hospital

back to top